anmelden
FTSE All-Share
5.794,00
PKT
-20,48
PKT
-0,35
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.07.18 | GSK overweight | Barclays Capital | |
| 30.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 30.07.18 | BAT Outperform | Credit Suisse Group | |
| 30.07.18 | Diageo Hold | Deutsche Bank AG | |
| 30.07.18 | GSK Hold | Kepler Cheuvreux | |
| 30.07.18 | BAT buy | Société Générale Group S.A. (SG) | |
| 30.07.18 | BT Group Hold | S&P Capital IQ | |
| 28.07.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 27.07.18 | BP overweight | JP Morgan Chase & Co. | |
| 27.07.18 | GSK buy | HSBC | |
| 27.07.18 | Diageo Outperform | Credit Suisse Group | |
| 27.07.18 | Diageo market-perform | Bernstein Research | |
| 27.07.18 | BP buy | UBS AG | |
| 27.07.18 | Diageo buy | Société Générale Group S.A. (SG) | |
| 27.07.18 | AstraZeneca Hold | S&P Capital IQ | |
| 27.07.18 | Diageo Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.07.18 | Diageo buy | S&P Capital IQ | |
| 27.07.18 | AstraZeneca overweight | Barclays Capital | |
| 27.07.18 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 27.07.18 | Shell (ex Royal Dutch Shell) buy | S&P Capital IQ | |
| 27.07.18 | BAT buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.07.18 | BAT buy | Deutsche Bank AG | |
| 27.07.18 | Shell (ex Royal Dutch Shell) Hold | Société Générale Group S.A. (SG) | |
| 27.07.18 | Shell (ex Royal Dutch Shell) overweight | Barclays Capital | |
| 27.07.18 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 27.07.18 | Diageo buy | Goldman Sachs Group Inc. | |
| 27.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 27.07.18 | BAT buy | Goldman Sachs Group Inc. | |
| 26.07.18 | Vodafone Group Outperform | RBC Capital Markets | |
| 26.07.18 | Diageo Sector Perform | RBC Capital Markets | |
| 26.07.18 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 26.07.18 | BAT buy | Goldman Sachs Group Inc. | |
| 26.07.18 | GSK buy | UBS AG | |
| 26.07.18 | GSK Hold | S&P Capital IQ | |
| 26.07.18 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 26.07.18 | Vodafone Group overweight | Barclays Capital | |
| 26.07.18 | AstraZeneca Neutral | UBS AG | |
| 26.07.18 | Vodafone Group buy | Deutsche Bank AG | |
| 26.07.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.07.18 | Diageo buy | UBS AG |
